AG
GILD icon

AmeriFlex Group’s Gilead Sciences GILD Stock Holding History

AmeriFlex Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Sell
1,064
-176
-14% -$24.6K 0.08% 215
2025
Q4 		$152K Sell
1,240
-1,240
-50% -$151K 0.08% 209
2025
Q3 		$275K Buy
2,480
+1,192
+93% +$135K 0.1% 164
2025
Q2 		$139K Sell
1,288
-1,640
-56% -$175K 0.07% 218
2025
Q1 		$328K Buy
2,928
+207
+8% +$21.4K 0.13% 155
2024
Q4 		$264K Buy
+2,721
New +$245K 0.12% 160

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AmeriFlex Group's GILD Position: Q1 2026 in Review

AmeriFlex Group reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $24.6K and leaving 1,064 shares worth $148K. The position accounts for 0.08% of the portfolio, ranked #215.

AmeriFlex Group first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $328K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AmeriFlex Group held 1,064 shares of Gilead Sciences worth $148K as of Q1 2026.
  • AmeriFlex Group sold 176 Gilead Sciences shares in Q1 2026, an estimated $24.6K.
  • Gilead Sciences made up 0.08% of AmeriFlex Group's portfolio in Q1 2026, its #215 holding.
  • AmeriFlex Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • AmeriFlex Group's Gilead Sciences position peaked at $328K in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.